Does HUMAN C1-ESTERASE INHIBITOR Cause Incorrect product administration duration? 70 Reports in FDA Database

Q: Does HUMAN C1-ESTERASE INHIBITOR cause Incorrect product administration duration?

70 reports of Incorrect product administration duration have been filed with the FDA for HUMAN C1-ESTERASE INHIBITOR, representing 0.5% of all HUMAN C1-ESTERASE INHIBITOR adverse event reports.

Q: How dangerous is Incorrect product administration duration from HUMAN C1-ESTERASE INHIBITOR?

Of 70 reports, 62 (88.6%) resulted in death and 67 required hospitalization.

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 70 reports of Incorrect product administration duration have been filed in association with HUMAN C1-ESTERASE INHIBITOR (Cinryze). This represents 0.5% of all adverse event reports for HUMAN C1-ESTERASE INHIBITOR.

Reports of Incorrect product administration duration with HUMAN C1-ESTERASE INHIBITOR

0.5%

of all HUMAN C1-ESTERASE INHIBITOR reports

Deaths

Hospitalizations

How Dangerous Is Incorrect product administration duration From HUMAN C1-ESTERASE INHIBITOR?

Of the 70 reports, 62 (88.6%) resulted in death, 67 (95.7%) required hospitalization, and 61 (87.1%) were considered life-threatening.

Is Incorrect product administration duration Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for HUMAN C1-ESTERASE INHIBITOR. However, 70 reports have been filed with the FAERS database.

What Other Side Effects Does HUMAN C1-ESTERASE INHIBITOR Cause?

Hereditary angioedema (5,572) No adverse event (1,660) Off label use (1,614) Drug ineffective (1,426) Intentional product use issue (1,117) Product use in unapproved indication (1,003) Weight increased (897) Maternal exposure during pregnancy (869) Pain (822) Condition aggravated (775)

What Other Drugs Cause Incorrect product administration duration?

ETONOGESTREL (3,974) POLYETHYLENE GLYCOL 3350 (2,129) NIRMATRELVIR\RITONAVIR (744) DOCOSANOL (634) LANSOPRAZOLE (564) LOPERAMIDE (543) NAPROXEN (499) INSULIN LISPRO (479) DICLOFENAC (362) OMEPRAZOLE (302)

Which HUMAN C1-ESTERASE INHIBITOR Alternatives Have Lower Incorrect product administration duration Risk?

HUMAN C1-ESTERASE INHIBITOR vs HUMAN COAGULATION FACTOR VIII/VON WILLEBRAND FACTOR COMPLEX HUMAN C1-ESTERASE INHIBITOR vs HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN HUMAN C1-ESTERASE INHIBITOR vs HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN HUMAN C1-ESTERASE INHIBITOR vs HUMAN IMMUNOGLOBULIN G HUMAN C1-ESTERASE INHIBITOR vs HUMAN IMMUNOGLOBULIN G\HYALURONIDASE

HUMAN C1-ESTERASE INHIBITOR Full Profile All Incorrect product administration duration Reports All Drugs Causing Incorrect product administration duration HUMAN C1-ESTERASE INHIBITOR Demographics